
Jessica Weiss
Examiner (ID: 11689, Phone: (571)270-5597 , Office: P/3776 )
| Most Active Art Unit | 3775 |
| Art Unit(s) | 3775, 3776 |
| Total Applications | 789 |
| Issued Applications | 603 |
| Pending Applications | 83 |
| Abandoned Applications | 120 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12199671
[patent_doc_number] => 09902725
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-27
[patent_title] => 'Heterocyclic derivatives as RORgamma modulators'
[patent_app_type] => utility
[patent_app_number] => 15/539519
[patent_app_country] => US
[patent_app_date] => 2015-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 19
[patent_no_of_words] => 92344
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539519
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/539519 | Heterocyclic derivatives as RORgamma modulators | Dec 21, 2015 | Issued |
Array
(
[id] => 14099203
[patent_doc_number] => 20190091277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => METHODS FOR REDUCING PLATELET AGGREGATION AND TREATING CARDIOVASCULAR DISEASE AND OTHER MEDICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/536904
[patent_app_country] => US
[patent_app_date] => 2015-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -68
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536904
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/536904 | Methods for reducing platelet aggregation and treating cardiovascular disease and other medical disorders | Dec 17, 2015 | Issued |
Array
(
[id] => 10749722
[patent_doc_number] => 20160095872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-07
[patent_title] => 'Therapeutic Compositions Comprising Imidazole and Imidazolium Compounds'
[patent_app_type] => utility
[patent_app_number] => 14/968514
[patent_app_country] => US
[patent_app_date] => 2015-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13020
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14968514
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/968514 | Therapeutic compositions comprising imidazole and imidazolium compounds | Dec 13, 2015 | Issued |
Array
(
[id] => 11641142
[patent_doc_number] => 09662490
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => 'Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug'
[patent_app_type] => utility
[patent_app_number] => 14/967149
[patent_app_country] => US
[patent_app_date] => 2015-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 7257
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14967149
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/967149 | Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug | Dec 10, 2015 | Issued |
Array
(
[id] => 12975790
[patent_doc_number] => 20170340680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => USE OF A PARTICULAR EXTRACT OF PROPOLIS FOR COMBATING THE SIDE EFFECTS OF CHEMOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 15/534950
[patent_app_country] => US
[patent_app_date] => 2015-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4486
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15534950
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/534950 | Use of a particular extract of propolis for combating the side effects of chemotherapy | Dec 10, 2015 | Issued |
Array
(
[id] => 10743205
[patent_doc_number] => 20160089356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-31
[patent_title] => 'SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/962951
[patent_app_country] => US
[patent_app_date] => 2015-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 55311
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14962951
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/962951 | SUBSTITUTED ACYLANILIDES AND METHODS OF USE THEREOF | Dec 7, 2015 | Abandoned |
Array
(
[id] => 11074164
[patent_doc_number] => 20160271127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'CANNABINOID RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/956586
[patent_app_country] => US
[patent_app_date] => 2015-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 69050
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14956586
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/956586 | Cannabinoid receptor modulators | Dec 1, 2015 | Issued |
Array
(
[id] => 14029421
[patent_doc_number] => 10226441
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-12
[patent_title] => Aging inhibitor
[patent_app_type] => utility
[patent_app_number] => 15/534319
[patent_app_country] => US
[patent_app_date] => 2015-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 9490
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15534319
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/534319 | Aging inhibitor | Nov 30, 2015 | Issued |
Array
(
[id] => 12049850
[patent_doc_number] => 20170326194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'THERAPEUTIC COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/532417
[patent_app_country] => US
[patent_app_date] => 2015-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 6796
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15532417
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/532417 | THERAPEUTIC COMPOSITIONS | Nov 30, 2015 | Abandoned |
Array
(
[id] => 10729506
[patent_doc_number] => 20160075655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'ARYLALKYLAMINE COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/952252
[patent_app_country] => US
[patent_app_date] => 2015-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30104
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14952252
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/952252 | Arylalkylamine compounds as calcium sensing receptor modulators | Nov 24, 2015 | Issued |
Array
(
[id] => 12029532
[patent_doc_number] => 20170319631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'IMMUNITY GENERATION'
[patent_app_type] => utility
[patent_app_number] => 15/527376
[patent_app_country] => US
[patent_app_date] => 2015-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 1357
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15527376
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/527376 | Immunity generation | Nov 18, 2015 | Issued |
Array
(
[id] => 11588477
[patent_doc_number] => 20170112888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'EYE LENS AND METHOD FOR MAKING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/946321
[patent_app_country] => US
[patent_app_date] => 2015-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1647
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14946321
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/946321 | EYE LENS AND METHOD FOR MAKING SAME | Nov 18, 2015 | Abandoned |
Array
(
[id] => 10727482
[patent_doc_number] => 20160073631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'PROCESS FOR THE PREPARATION OF DIHYDROPYRROLE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/945924
[patent_app_country] => US
[patent_app_date] => 2015-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40938
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14945924
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/945924 | PROCESS FOR THE PREPARATION OF DIHYDROPYRROLE DERIVATIVES | Nov 18, 2015 | Abandoned |
Array
(
[id] => 12562692
[patent_doc_number] => 10016466
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-10
[patent_title] => Topical medicament for skin and mucosal injuries associated with
[patent_app_type] => utility
[patent_app_number] => 15/525629
[patent_app_country] => US
[patent_app_date] => 2015-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5581
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15525629
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/525629 | Topical medicament for skin and mucosal injuries associated with | Nov 12, 2015 | Issued |
Array
(
[id] => 10735838
[patent_doc_number] => 20160081988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'COMPOSITIONS OF 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS AND METHODS FOR THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 14/940345
[patent_app_country] => US
[patent_app_date] => 2015-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25880
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14940345
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/940345 | Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use | Nov 12, 2015 | Issued |
Array
(
[id] => 10782816
[patent_doc_number] => 20160128973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'INHIBITION OF CANCER CELL MOTILITY'
[patent_app_type] => utility
[patent_app_number] => 14/935040
[patent_app_country] => US
[patent_app_date] => 2015-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 57
[patent_no_of_words] => 22419
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14935040
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/935040 | Inhibition of cancer cell motility | Nov 5, 2015 | Issued |
Array
(
[id] => 12029533
[patent_doc_number] => 20170319632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'PROPHYLACTIC OR THERAPEUTIC AGENT FOR PEPTIC ULCER, FOOD ADDITIVE FOR PROPHYLACTIC OR THERAPEUTIC USE, INOS EXPRESSION INHIBITOR AND COX-2 EXPRESSION INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 15/524522
[patent_app_country] => US
[patent_app_date] => 2015-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7657
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524522
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/524522 | Prophylactic or therapeutic agent for peptic ulcer, food additive for prophylactic or therapeutic use, iNOS expression inhibitor and COX-2 expression inhibitor | Nov 5, 2015 | Issued |
Array
(
[id] => 14791581
[patent_doc_number] => 10398776
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-09-03
[patent_title] => Phonophoretic cannabidiol composition and transdermal delivery system
[patent_app_type] => utility
[patent_app_number] => 14/930979
[patent_app_country] => US
[patent_app_date] => 2015-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4138
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14930979
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/930979 | Phonophoretic cannabidiol composition and transdermal delivery system | Nov 2, 2015 | Issued |
Array
(
[id] => 14791509
[patent_doc_number] => 10398740
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-03
[patent_title] => Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency
[patent_app_type] => utility
[patent_app_number] => 15/523767
[patent_app_country] => US
[patent_app_date] => 2015-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 6741
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15523767
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/523767 | Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency | Nov 1, 2015 | Issued |
Array
(
[id] => 12057160
[patent_doc_number] => 20170333504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'FORMULATIONS CONTAINING POMEGRANATE SEED OIL, ROSA CANINA FRUIT OIL AND INULA VISCOSA OLEORESIN OR EXTRACT'
[patent_app_type] => utility
[patent_app_number] => 15/521978
[patent_app_country] => US
[patent_app_date] => 2015-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9258
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15521978
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/521978 | Formulations containing pomegranate seed oil, rosa canina fruit oil and inula viscosa oleoresin or extract | Nov 1, 2015 | Issued |